Argon neuroprotection

Critical Care

Volumn 14, Issue 1, 2010, Pages

  Sanders, Robert D ^a,b   Ma, Daqing ^b   Maze, Mervyn ^b,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ARGON; HELIUM; KRYPTON; MAMMALIAN TARGET OF RAPAMYCIN; N METHYL DEXTRO ASPARTIC ACID; NEON; XENON; NEUROPROTECTIVE AGENT;

BINDING SITE; BRAIN INJURY; CELL PROTECTION; NEUROPROTECTION; NOTE; PRIORITY JOURNAL; PROTEIN BINDING; ANIMAL; ANIMAL MODEL; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; IN VITRO STUDY; INJURY;

ANIMALS; ARGON; CENTRAL NERVOUS SYSTEM; MODELS, ANIMAL; NEUROPROTECTIVE AGENTS;

EID: 77956631204     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8847     Document Type: Note

References (15)

1. Loetscher PD, Rossaint J, Rossaint R, Weis J, Fries M, Fahlenkamp A, Ryang YM, Grottke O, Coburn M. Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care 2009, 13:R206. 2811924, 20017934, 10.1186/cc8214.
2. Coburn M, Maze M, Franks NP. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med 2008, 36:588-595. 10.1097/01.CCM.0B013E3181611F8A6, 18216607.
3. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, Ma D. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 2009, 460:232-236. 10.1016/j.neulet.2009.05.069, 19500647.
4. Sanders RD, Ma D, Maze M. Xenon: elemental anaesthesia in clinical practice. Br Med Bull 2004, 71:115-135. 10.1093/bmb/ldh034, 15728132.
5. Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, Mehmet H, Edwards AD, Franks NP, Maze M. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005, 58:182-193. 10.1002/ana.20547, 16049939.
6. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH, . STAIR Group Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009, 40:2244-2250. 10.1161/STROKEAHA.108.541128, 19246690, STAIR Group.
7. Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, Warltier DC, Pratt PF. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo . Anesth Analg 2007, 105:562-569. 10.1213/01.ane.0000278083.31991.36, 17717207.
8. David HN, Haelewyn B, Chazalviel L, Lecocq M, Degoulet M, Risso JJ, Abraini JH. Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia. J Cereb Blood Flow Metab 2009, 29:1159-1165. 10.1038/jcbfm.2009.40, 19384333.
9. Bertaccini EJ, Trudell JR, Franks NP. The common chemical motifs within anesthetic binding sites. Anesth Analg 2007, 104:318-324. 10.1213/01.ane.0000253029.67331.8d, 17242087.
10. Trudell JR, Koblin DD, Eger EI. A molecular description of how noble gases and nitrogen bind to a model site of anesthetic action. Anesth Analg 1998, 87:411-418. 10.1097/00000539-199808000-00034, 9706942.
11. Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR. How does xenon produce anaesthesia?. Nature 1998, 396:324. 10.1038/24525, 9845069.
12. Bantel C, Maze M, Trapp S. Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 2009, 110:986-995. 10.1097/ALN.0b013e31819dadc7, 19352153.
13. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-poredomain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004, 65:443-452. 10.1124/mol.65.2.443, 14742687.
14. Ma D, Lim T, Xu J, Tang H, Wan Y, Zhao H, Hossain M, Maxwell PH, Maze M. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol 2009, 20:713-720. 10.1681/ASN.2008070712, 19144758.
15. Koblin DD, Fang Z, Eger EI, Laster MJ, Gong D, Ionescu P, Halsey MJ, Trudell JR. Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics). Anesth Analg 1998, 87:419-424. 10.1097/00000539-199808000-00035, 9706943.